Priority Date: 23.11.11 (US 201161563507P)

NUCLEIC ACID VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE

  • Application ID: EP12851895
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 11 - 50 employees
Company dna eip1
operating since 2009
1104.09
Headquarter in London and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 130 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 23.11.2011 - Priority Date (US 201161563507P)
  • 30.05.2013 - Publication A1 (WO2013078299)
  • 01.10.2014 - Publication A1 (EP2782597)